Castle Biosciences (CSTL) Treasury Shares (2020 - 2026)

Castle Biosciences (CSTL) has 7 years of Treasury Shares data on file, last reported at $433784.0 in Q1 2026.

• Quarterly Treasury Shares changed N/A year-over-year to $433784.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $433784.0 (changed N/A YoY) and the FY2025 annual result came in at $350144.0, down 89.05% from the prior year.
• Treasury Shares climbed to $433784.0 in Q1 2026 per CSTL's latest filing, from $350144.0 in the prior quarter.
• The five-year high for Treasury Shares was $3.9 million in Q3 2025, with the low at $196033.0 in Q4 2022.
• Average Treasury Shares over 5 years is $1.4 million, with a median of $391964.0 recorded in 2025.
• Year-over-year, Treasury Shares soared 1530.45% in 2024 and plunged 89.05% in 2025.
• Castle Biosciences' Treasury Shares stood at $196033.0 in 2022, then changed by 0.0% to $196033.0 in 2023, then soared by 1530.45% to $3.2 million in 2024, then sank by 89.05% to $350144.0 in 2025, then climbed by 23.89% to $433784.0 in 2026.
• Business Quant data shows CSTL's Treasury Shares at $433784.0 in Q1 2026, $350144.0 in Q4 2025, and $3.9 million in Q3 2025.